Effect and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis Patients
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02605213 |
|
Recruitment Status : Unknown
Verified November 2015 by Nasser Ebrahim Daryani, Tehran University of Medical Sciences.
Recruitment status was: Recruiting
First Posted : November 16, 2015
Last Update Posted : November 16, 2015
|
Sponsor:
Tehran University of Medical Sciences
Information provided by (Responsible Party):
Nasser Ebrahim Daryani, Tehran University of Medical Sciences
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | February 2016 |
| Estimated Study Completion Date : | February 2016 |